Rubric Capital Management LP Ani Pharmaceuticals Inc Transaction History

Rubric Capital Management LP

$6.05 Billion
Q4 2024

A detailed history of Rubric Capital Management LP transactions in Ani Pharmaceuticals Inc stock. As of the latest transaction made, Rubric Capital Management LP holds 56,671 shares of ANIP stock, worth $3.33 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

56,671

Previous 56,671 -0.0%

Holding current value

$3.33 Million

Previous $3.38 Million 7.34%

% of portfolio

0.05%

Previous 0.09%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$54.33 - $65.72 $29.7 Million - $36 Million	-547,129 Reduced 90.61%	56,671 $3.38 Million
Q2 2024 Aug 13, 2024	SELL	$58.53 - $68.82 $20.8 Million - $24.4 Million	-354,733 Reduced 37.01%	603,800 $38.4 Million
Q1 2024 May 10, 2024	SELL	$54.2 - $69.69 $9.02 Million - $11.6 Million	-166,467 Reduced 14.8%	958,533 $66.3 Million
Q4 2023 Feb 13, 2024	BUY	$48.72 - $65.43 $13.5 Million - $18.2 Million	277,989 Added 32.82%	1,125,000 $62 Million
Q2 2023 Aug 11, 2023	BUY	$37.29 - $53.83 $7.42 Million - $10.7 Million	198,970 Added 30.7%	847,011 $45.6 Million
Q1 2023 May 12, 2023	BUY	$37.61 - $45.72 $10.2 Million - $12.4 Million	271,909 Added 72.29%	648,041 $25.7 Million
Q4 2022 Feb 10, 2023	BUY	$31.9 - $41.95 $2.84 Million - $3.74 Million	89,086 Added 31.04%	376,132 $15.1 Million
Q3 2022 Nov 14, 2022	BUY	$29.83 - $38.01 $6.1 Million - $7.78 Million	204,602 Added 248.17%	287,046 $9.23 Million
Q2 2022 Aug 15, 2022	BUY	$23.09 - $33.46 $1.9 Million - $2.76 Million	82,444 New	82,444 $2.45 Million
Q1 2022 May 13, 2022	SELL	$26.91 - $47.15 $8.28 Million - $14.5 Million	-307,557 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$32.97 - $56.85 $10.1 Million - $17.5 Million	307,557 New	307,557 $14.2 Million

Others Institutions Holding ANIP

# of Institutions

211

Shares Held

19.2M

Call Options Held

3.4K

Put Options Held

10.8K

View Full List

About ANI PHARMACEUTICALS INC

Ticker ANIP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 17,426,000
Market Cap $1.02B
Description
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...

More about ANIP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rubric Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Rubric Capital Management LP with notifications on news.

Account

Rubric Capital Management LP Ani Pharmaceuticals Inc Transaction History